Correlation Between Verrica Pharmaceuticals and Genfit
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Genfit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Genfit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Genfit, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Genfit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Genfit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Genfit.
Diversification Opportunities for Verrica Pharmaceuticals and Genfit
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Verrica and Genfit is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Genfit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genfit and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Genfit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genfit has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Genfit go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Genfit
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to under-perform the Genfit. In addition to that, Verrica Pharmaceuticals is 1.68 times more volatile than Genfit. It trades about -0.03 of its total potential returns per unit of risk. Genfit is currently generating about 0.02 per unit of volatility. If you would invest 420.00 in Genfit on August 27, 2024 and sell it today you would earn a total of 0.00 from holding Genfit or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Genfit
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Genfit |
Verrica Pharmaceuticals and Genfit Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Genfit
The main advantage of trading using opposite Verrica Pharmaceuticals and Genfit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Genfit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genfit will offset losses from the drop in Genfit's long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| Genfit vs. Eliem Therapeutics | Genfit vs. HCW Biologics | Genfit vs. Scpharmaceuticals | Genfit vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |